Target Analysis

Discerning the best route to a new drug candidate can often be illuminated by building a comprehensive knowledge of a target in order to choose the best approach for a drug discovery project. A comprehensive target analysis allows our experts to adopt an optimal hit finding strategy and ultimately to design better, selective compounds.

Sygnature scientists are able to apply a range of computational techniques to help you gain a deep understanding of your target and to complement any biological validation.

  • Binding site identification and druggability assessment of new biological targets, including exploration of cryptic/transient binding pockets via SILCSBio Fragmaps.
  • Protein sequence analysis, multiple sequences alignments and selectivity analysis.
  • Analysis of available structural data and protein structure visualisation shared with medicinal chemists to empower them to design improved compounds.
  • Homology modelling for targets lacking specific structural information.
  • Water assessment to understand the role of water in molecular interactions and its impact on binding affinity.

Latest News

View All

Sygnature Discovery and UBE Corporation successfully identify…

Five Arrows invests in Sygnature Discovery

Sygnature Discovery’s Early CMC Development Expansion: Unveiling…

Sygnature Discovery expands US presence with Bay…